Silverfin false 31/03/2023 01/04/2022 31/03/2023 Dr P T Reid 24/02/2012 Dr E S Wilkinson 24/02/2012 16 October 2023 no description of principal activity SC417861 2023-03-31 SC417861 bus:Director1 2023-03-31 SC417861 bus:Director2 2023-03-31 SC417861 2022-03-31 SC417861 core:CurrentFinancialInstruments 2023-03-31 SC417861 core:CurrentFinancialInstruments 2022-03-31 SC417861 core:ShareCapital 2023-03-31 SC417861 core:ShareCapital 2022-03-31 SC417861 core:RetainedEarningsAccumulatedLosses 2023-03-31 SC417861 core:RetainedEarningsAccumulatedLosses 2022-03-31 SC417861 core:PlantMachinery 2022-03-31 SC417861 core:Vehicles 2022-03-31 SC417861 core:FurnitureFittings 2022-03-31 SC417861 core:ComputerEquipment 2022-03-31 SC417861 core:PlantMachinery 2023-03-31 SC417861 core:Vehicles 2023-03-31 SC417861 core:FurnitureFittings 2023-03-31 SC417861 core:ComputerEquipment 2023-03-31 SC417861 bus:OrdinaryShareClass1 2023-03-31 SC417861 2022-04-01 2023-03-31 SC417861 bus:FullAccounts 2022-04-01 2023-03-31 SC417861 bus:SmallEntities 2022-04-01 2023-03-31 SC417861 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 SC417861 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 SC417861 bus:Director1 2022-04-01 2023-03-31 SC417861 bus:Director2 2022-04-01 2023-03-31 SC417861 core:PlantMachinery core:TopRangeValue 2022-04-01 2023-03-31 SC417861 core:Vehicles 2022-04-01 2023-03-31 SC417861 core:FurnitureFittings core:TopRangeValue 2022-04-01 2023-03-31 SC417861 core:ComputerEquipment core:TopRangeValue 2022-04-01 2023-03-31 SC417861 2021-04-01 2022-03-31 SC417861 core:PlantMachinery 2022-04-01 2023-03-31 SC417861 core:FurnitureFittings 2022-04-01 2023-03-31 SC417861 core:ComputerEquipment 2022-04-01 2023-03-31 SC417861 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 SC417861 bus:OrdinaryShareClass1 2021-04-01 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC417861 (Scotland)

REID WILKINSON MEDICAL LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2023
PAGES FOR FILING WITH THE REGISTRAR

REID WILKINSON MEDICAL LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2023

Contents

REID WILKINSON MEDICAL LIMITED

BALANCE SHEET

AS AT 31 MARCH 2023
REID WILKINSON MEDICAL LIMITED

BALANCE SHEET (continued)

AS AT 31 MARCH 2023
Note 2023 2022
£ £
Fixed assets
Tangible assets 3 59,693 77,629
59,693 77,629
Current assets
Debtors 4 87,553 217,969
Cash at bank and in hand 5 1,051,829 959,381
1,139,382 1,177,350
Creditors: amounts falling due within one year 6 ( 27,184) ( 49,629)
Net current assets 1,112,198 1,127,721
Total assets less current liabilities 1,171,891 1,205,350
Provision for liabilities 7 ( 11,905) ( 19,408)
Net assets 1,159,986 1,185,942
Capital and reserves
Called-up share capital 8 10 10
Profit and loss account 1,159,976 1,185,932
Total shareholders' funds 1,159,986 1,185,942

For the financial year ending 31 March 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Reid Wilkinson Medical Limited (registered number: SC417861) were approved and authorised for issue by the Director on 16 October 2023. They were signed on its behalf by:

Dr P T Reid
Director
REID WILKINSON MEDICAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2023
REID WILKINSON MEDICAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Reid Wilkinson Medical Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is 19 Cumin Place, Edinburgh, EH9 2JX, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for the sale of medical supplies and is shown net of VAT and other sales related taxes.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Taxation

Current tax
Current tax is provided at amounts expected to be paid using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery 5 years straight line
Vehicles 25 % reducing balance
Fixtures and fittings 5 years straight line
Computer equipment 5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand and deposits held at call with banks.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors are recognised at transaction price.

Trade Creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Plant and machinery Vehicles Fixtures and fittings Computer equipment Total
£ £ £ £ £
Cost
At 01 April 2022 3,997 75,128 923 5,711 85,759
Additions 0 0 0 1,844 1,844
At 31 March 2023 3,997 75,128 923 7,555 87,603
Accumulated depreciation
At 01 April 2022 3,997 1,555 400 2,178 8,130
Charge for the financial year 0 18,393 185 1,202 19,780
At 31 March 2023 3,997 19,948 585 3,380 27,910
Net book value
At 31 March 2023 0 55,180 338 4,175 59,693
At 31 March 2022 0 73,573 523 3,533 77,629

4. Debtors

2023 2022
£ £
Trade debtors 86,212 217,016
Other debtors 1,341 953
87,553 217,969

5. Cash and cash equivalents

2023 2022
£ £
Cash at bank and in hand 1,051,829 959,381

6. Creditors: amounts falling due within one year

2023 2022
£ £
Taxation and social security 22,024 45,589
Other creditors 5,160 4,040
27,184 49,629

7. Provision for liabilities

2023 2022
£ £
Deferred tax 11,905 19,408

8. Called-up share capital

2023 2022
£ £
Allotted, called-up and fully-paid
10 Ordinary shares of £ 1.00 each 10 10